Optimization methods for large-scale vaccine supply chains: a rapid reviewAnnals of Operations Research - Global vaccine revenues are projected at $59.2 billion, yet large-scale vaccine distribution remains challenging for many diseases in countries around the world...doi...
Given the importance of moving quickly to roll out the vaccine to reach a herd immunity threshold, and the current situation of insufficient supply to meet the current global demand, addressing this reluctance through evidence gained from this study would be advantageous. It is of paramount ...
the risk that we may not be able to maintain manufacturing capacity or access to logistics or supply channels commensurate with global demand for our vaccines, which would negatively impact our ability to supply our vaccines within the projected time periods; whether and when...
Overview of the solution The platform is built on a smart logistics supply chain system and provides intelligent solutions for the vaccine and drug supply chain. It integrates order, warehousing, and transportation management to connect pharmaceutical factories, disease control centers, vaccination units,...
Along with the loss of human life, the pandemic has led to unprecedented public health challenges, stressing health care systems, disrupting supply chains and economies, and prompting a mental health crisis [2, 3]. Simultaneously, several COVID-19 vaccines have been developed and approved at an...
Johnson & Johnson announces a lead vaccine candidate for COVID-19; landmark new partnership with US department of health & human services; and commitment to supply one billion vaccines worldwide for emergency pandemic use.https://www.jnj.com/johnson-johnson-announces-a-lead-vaccine-candidate-for...
Six critical vaccine attributes (safety, effectiveness, product quality, supply, demand, and value) contribute to optimally achieving impact. A favorable and sustainable value proposition for a KSHV vaccine must balance affordability and acceptability against sustainability by manufacturers and those procuring...
Pfizer has signed a nearly $2-billion contract with the US government to provide 100 million doses for free, though the New York Times reports that only half its supply will go to the USA this year. Canadian health officials have also granted emergency approval to Pfizer’s COVID-19 ...
BCG vaccine has been in short supply owing to high demand and manufacturing restrictions. The global BCG shortage in 2016 and 2019 has led to changes in the management of BCG for the treatment of bladder cancer. Hence, many countries have decreased the dosage and limited the usage of BCG. ...
During commercial production and distribution, vaccine instability and potency loss can potentially occur across the entire vaccine supply chain from the manufacturer to patient administration. Because of the temperature sensitive nature of vaccines, the supply chain requires maintenance of either refrigerated...